HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dashyant Dhanak Selected Research

SB-611812

11/2006Urotensin-II receptor blockade with SB-611812 attenuates cardiac remodeling in experimental ischemic heart disease.
8/2006Urotensin-II blockade with SB-611812 attenuates cardiac dysfunction in a rat model of coronary artery ligation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dashyant Dhanak Research Topics

Disease

17Neoplasms (Cancer)
01/2018 - 12/2004
3Lymphoma (Lymphomas)
12/2014 - 12/2012
2Carcinogenesis
06/2014 - 01/2013
2Leukemia
05/2010 - 07/2009
2Heart Failure
11/2006 - 08/2006
1Human Influenza (Influenza)
01/2019
1Virus Diseases (Viral Diseases)
01/2019
1Carcinoma (Carcinomatosis)
06/2014
1Neuroblastoma
01/2013
1Colonic Neoplasms (Colon Cancer)
05/2010
1Epilepsy (Aura)
05/2009
1Cardiovascular Diseases (Cardiovascular Disease)
11/2006
1Fibrosis (Cirrhosis)
11/2006
1Myocardial Ischemia (Ischemic Heart Diseases)
11/2006
1Hypertrophy
08/2006
1Edema (Dropsy)
08/2006
1Vascular Remodeling
11/2005

Drug/Important Bio-Agent (IBA)

6Histones (Histone)IBA
12/2014 - 07/2009
3MethyltransferasesIBA
06/2014 - 12/2012
3Phosphotransferases (Kinase)IBA
06/2014 - 01/2008
3urotensin IIIBA
11/2006 - 11/2005
2Lysine (L-Lysine)FDA Link
06/2014 - 03/2014
2Proteins (Proteins, Gene)FDA Link
01/2013 - 11/2006
2Serine (L-Serine)FDA Link
05/2010 - 07/2009
2Aurora KinasesIBA
05/2010 - 05/2009
2KinesinsIBA
04/2010 - 12/2004
2SB-611812IBA
11/2006 - 08/2006
1ARS-1620IBA
01/2018
1Biological ProductsIBA
09/2017
1Immune Checkpoint ProteinsIBA
09/2017
1Carrier Proteins (Binding Protein)IBA
12/2014
1Heme (Haem)IBA
12/2014
1ChromatinIBA
12/2014
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
06/2014
14- (1- acetyl- 4- ((4- chlorophenyl)amino)- 2- methyl- 1,2,3,4- tetrahydroquinolin- 6- yl)benzoic acidIBA
01/2013
1EnzymesIBA
12/2012
1omipalisibIBA
04/2010
1BenzenesulfonamidesIBA
04/2010
1Phosphatidylinositols (Phosphatidylinositol)IBA
04/2010
1Aurora Kinase BIBA
07/2009
1Protein Kinases (Protein Kinase)IBA
07/2009
1GSK 1070916IBA
07/2009
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
05/2009
1ispinesibIBA
06/2008
1KSPA-1IBA
06/2008
1LipidsIBA
01/2008
1Insulin Receptor Substrate ProteinsIBA
01/2008
1Adenosine Triphosphate (ATP)IBA
10/2007
1C.I. direct red 80IBA
11/2006
1Collagen Type I (Type I Collagen)IBA
11/2006
1Peptides (Polypeptides)IBA
11/2005
1CollagenIBA
11/2005
1ATP Citrate (pro-S)-Lyase (Citrate Synthase, ATP)IBA
10/2005
1Glucose (Dextrose)FDA LinkGeneric
10/2005
1Antimitotic AgentsIBA
12/2004

Therapy/Procedure

5Therapeutics
12/2014 - 12/2004
2Oral Administration
01/2019 - 01/2013
1Immunotherapy
09/2017
1Ligation
11/2006